相关实验视频

Updated: Jan 11, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

向细胞因子:重塑胰腺瘤的微环境

Dhana Sekhar Reddy Bandi¹, Siva Chander Chabattula¹, Hasitha Pynam²

¹Department of Hematology and Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

Cytokine & growth factor reviews

|November 11, 2025

概括

细胞因子在胰腺癌中起着双重作用,影响生长和转移. 准这些信号分子为针对PDAC的新型组合疗法提供了潜力.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

胰腺管腺癌 (PDAC) 的特征是具有多种细胞类型的复杂瘤微环境 (TME).
细胞因子,小信号分子,是PDAC中的关键调解者,影响癌细胞的增殖,分化,TME调节和转移.

研究的目的:

审查目前对细胞因子及其在PDAC中的多方面的作用的理解.
探索向细胞因子和细胞因子受体的潜力,以获得治疗效益.
总结涉及细胞因子与免疫检查点抑制剂和常规化疗的新型组合疗法.

主要方法:

关于PDAC中细胞因子的当前研究的文献综述.
分析细胞因子作为免疫抑制剂和免疫增强剂的双重作用.
使用细胞因子的组合疗法近期进展的摘要.

主要成果:

细胞因子显著影响PDAC进展,免疫逃避和治疗耐药性.
向细胞因子信号传递是PDAC治疗的一个有希望的策略.
与细胞因子的联合疗法显示出对PDAC生长和转移的增强疗效的潜力.

结论:

细胞因子是PDAC病原和免疫调节中的关键参与者.
向细胞因子,特别是在组合疗法中,对改善PDAC治疗结果具有显著的希望.
进一步的翻译研究和临床试验对于优化基于细胞因子的治疗策略至关重要.

关键词:

细胞因子 (cytokines) 是一种细胞因子.免疫检查点抑制剂免疫检查点抑制剂转移转移转移转移我们的PDAC是PDAC.翻译研究是翻译研究.瘤微环境是一个微环境.

更多相关视频

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...